| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/04/2006 | EP0818991B1 Controlled release insufflation carrier for medicaments comprising xanthan gum and locust bean gum |
| 01/04/2006 | EP0668931B1 Nucleic acid ligands and methods for producing the same |
| 01/04/2006 | CN1717252A Preparation containing basic drug |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1717226A Warm poultice |
| 01/04/2006 | CN1717223A Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 01/04/2006 | CN1717209A Cyclodextrin-based materials, compositions and uses related thereto |
| 01/04/2006 | CN1717181A Method of inhibiting acrylamide formation and use thereof |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1714868A Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1714783A Implantable particles for tissue bulking and the treatment |
| 01/04/2006 | CN1234744C Cosmetics agent |
| 01/04/2006 | CN1234742C Application of copolymer including N-vinyl pyrrolidone and vinyl acetate |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234426C Topical pharmaceutical formulation |
| 01/04/2006 | CN1234416C Compositions for sustained delivery of hydrophobic drugs and process for preparation thereof |
| 01/04/2006 | CN1234415C Medical powder |
| 01/04/2006 | CN1234372C Use of bioactive fraction from cow urine distillate ( Go-mutra ) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 01/04/2006 | CN1234364C Gel composition for killing parasites |
| 01/04/2006 | CN1234363C Freezing-dried composition contg. dexrazoxane and its prepn. method |
| 01/04/2006 | CN1234348C Plant hard hollow capsule and its preparing method |
| 01/04/2006 | CN1234347C Anti-virus composition |
| 01/04/2006 | CN1234346C Optimised formulation of tobramycin for aeroselization |
| 01/04/2006 | CN1234345C Lubrication assistant and process for preparation of ethyl stearate used therein |
| 01/03/2006 | US6982327 Methods for producing and transforming cassava protoplasts |
| 01/03/2006 | US6982298 for tissue engineering or artificial tissue such as cartilage; hydrogels; tyramine-substituted hyaluronan molecules that are linked by dityramine bonds for example |
| 01/03/2006 | US6982282 Emulsion vehicle for poorly soluble drugs |
| 01/03/2006 | US6982281 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 01/03/2006 | US6982256 Containing cyclodextrin to improve local tolerance of the intravenously administered guanidine derivative |
| 01/03/2006 | US6982255 Comprises coadministration of galactomannan and chemotherapeutic agent (adriamycin) |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982248 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| 01/03/2006 | US6982154 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 01/03/2006 | US6982099 Composition and method for smoke detoxification |
| 01/03/2006 | US6982092 Method of complexing a nucleic acid with a lipid-conjugated polyamide |
| 01/03/2006 | US6982091 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/03/2006 | US6982088 Vaccine composition and stabilization method using high molecular weight PVP |
| 01/03/2006 | US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 01/03/2006 | US6982083 Starch granules containing a recombinant polypeptide of interest, method for obtaining them, and their uses |
| 01/03/2006 | US6982080 Hydroxyethyl starch—containing polypeptide compositions |
| 01/03/2006 | US6982079 Administering to eye drug with vasoconstriction and carrier |
| 01/03/2006 | CA2345818C Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 01/03/2006 | CA2339992C Orally disintegrable tablet forming a viscous slurry |
| 01/03/2006 | CA2316834C Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom |
| 01/03/2006 | CA2278639C Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties |
| 01/03/2006 | CA2266589C Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 01/03/2006 | CA2138974C Dermatological agent for aiding oxygen transport in the skin |
| 01/03/2006 | CA2129755C Stabilized radiopharmaceutical kits |
| 12/30/2005 | CA2511084A1 Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications |
| 12/30/2005 | CA2510985A1 Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same |
| 12/29/2005 | WO2005123907A2 Ex-vivo application of solid microparticulate therapeutic agents |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123676A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | WO2005123140A2 Preparation of macromolecular conjugates by four-component condensation reaction |
| 12/29/2005 | WO2005123139A1 Bifunctional derivatives of polyethylene glycol, their preparation and use |
| 12/29/2005 | WO2005123138A1 Pharmaceutical pellet compositions for controlled release |
| 12/29/2005 | WO2005123137A2 Lyophilized pharmaceutical composition comprising moxifloxacin hydrochloride |
| 12/29/2005 | WO2005123136A1 Antiinflammatory and analgesic preparation for external use |
| 12/29/2005 | WO2005123135A1 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
| 12/29/2005 | WO2005123134A2 A controlled release delivery system for metformin |
| 12/29/2005 | WO2005123133A1 A process for preparing ibuprofen soft gelatin capsules |
| 12/29/2005 | WO2005123120A1 Sustained release vaccine composition |
| 12/29/2005 | WO2005123114A2 Silk-based drug delivery system |
| 12/29/2005 | WO2005123109A2 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 12/29/2005 | WO2005123092A1 Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof |
| 12/29/2005 | WO2005123091A1 Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| 12/29/2005 | WO2005123090A1 Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase |
| 12/29/2005 | WO2005123078A1 Liposome preparation containing slightly water-soluble camptothecin |
| 12/29/2005 | WO2005123046A1 Novel transdermal preparation and its producing method |
| 12/29/2005 | WO2005123040A1 Tablet rapidly disintegrating in mouth |
| 12/29/2005 | WO2005123037A1 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 12/29/2005 | WO2005123035A1 Hydrophobic ophthalmic compositions and methods of use |
| 12/29/2005 | WO2005096717A3 Agent exhibiting hepatoprotective properties |
| 12/29/2005 | WO2005079398A3 Drug conjugates |
| 12/29/2005 | WO2005072343A3 Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use |
| 12/29/2005 | WO2005065121A3 Methods and compositions for the production of monoclonal antibodies |
| 12/29/2005 | WO2005060939A3 Controlled-release pharmaceutical formulation |
| 12/29/2005 | WO2005058244A3 Novel anti-dc-sign antibodies |
| 12/29/2005 | WO2005040353A3 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv |
| 12/29/2005 | WO2005040352A3 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 12/29/2005 | WO2005024038A3 Process for producing a capsular polysaccharide for use in conjugate vaccines |
| 12/29/2005 | WO2005016115A3 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 12/29/2005 | WO2004074437A3 Compositions and methods for cancer immunotherapy |
| 12/29/2005 | WO2004021861A3 Targeted release |
| 12/29/2005 | US20050288490 Polyether with glycerol backbone; capable of being labeled |
| 12/29/2005 | US20050288374 Chemical stabilization of solubilized retinoids and aqueous compositions comprised thereof |
| 12/29/2005 | US20050288276 Pharmaceutical formulation of olanzapine |
| 12/29/2005 | US20050288261 Compositions and method for treating infection in cattle and swine |
| 12/29/2005 | US20050288257 Novel stable compositions of water and oxygen sensitive compounds and their method of preparation |
| 12/29/2005 | US20050288235 Sodium chloride; dextran, carboxymethyl starch, sodium alginate, pentahydroxyethyl starch, gelatin derivatives or pectin; NaHCO3, KCl, MgSO4, CaCl, calcium gluconate, calcium lactate, sodium lactate, and/or Tris buffer; total Na ion does not exceed equivalent concentration of 6.9% (w/v); traumatic shock |
| 12/29/2005 | US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 12/29/2005 | US20050288222 Methods for enhancing the bioavailability of a drug |
| 12/29/2005 | US20050288197 Silicone polymer topical eye compositions and methods of use |
| 12/29/2005 | US20050288196 Silicone polymer contact lens compositions and methods of use |
| 12/29/2005 | US20050287628 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 12/29/2005 | US20050287552 Enclosed metallic nanoparticles for use as diagnostic and drug delivery tools |
| 12/29/2005 | US20050287220 solvent selected from glycerol formal, ethyl lactate, and hydroxypropyl methylcellulose; antibacterial agent, antifungal agent, antiparasitic agent, antiyeast agent, antiviral agent, antiinflammatory agent; gel for controlled or sustained release; infection of the skin, ear, or eye; veterinary medicine |